Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
10/2001
10/10/2001EP0923566A4 High molecular weight polymer-based prodrugs
10/10/2001EP0922044B1 Pyrrolo(3,2-c) quinoline derivatives
10/10/2001CN1317005A Substituted pyrazole derivatives condensed with six-membered heterocyclic rings
10/10/2001CN1316998A Thiobenzimidazole derivatives
10/10/2001CN1072647C Novel inhibitors of bone reabsorption and antagonists of vitronectin receptors
10/09/2001US6300500 Preparation of pyridone derivatives using phthalimido containing starting material
10/09/2001US6300341 2-substituted heterocyclic sulfonamides
10/09/2001US6300339 Compounds, their preparation and use
10/09/2001US6300331 Naphthalimidobenzamide derivatives
10/09/2001US6300329 Heterocyclic pyrido(1,2-a)pyrazine compounds for treatment of parkinson's disease
10/09/2001CA2177147C 2-oxoindoline derivative
10/04/2001WO2001072757A1 Tricyclic imidazopyridines
10/04/2001WO2001072756A1 Prodrugs of imidazopyridine derivatives
10/04/2001WO2001072755A1 Pyrano[2,3-c]imidazo[-1,2-a]pyridine derivatives for the treatment of gastrointestinal disorders
10/04/2001WO2001072754A1 Alkylated imidazopyridine derivatives
10/04/2001WO2001072749A1 Condensed pyrazole derivatives, process for producing the same and use thereof
10/04/2001WO2001072748A1 Imidazopyridin-8-ones
10/04/2001WO2001072718A1 Pharmaceutical compositions containing as the active ingredient nitropyrimidine derivatives or salts thereof
10/04/2001WO2001072711A1 3-cyanoquinolines,3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
10/04/2001WO2001072696A1 Arthropodicidal carboxanilides
10/04/2001WO2001072411A1 Reaction device for organic synthesis
10/04/2001WO2001019828A3 Kinase inhibitors as therapeutic agents
10/04/2001US20010027197 Antiproliverative, -carcinogenic and -tumor agents; mitogenesis-activated protein kinase inhibitors; noncytotoxic; binding with high affinity at the adenosine triphosphate binding site of the kinases
10/04/2001EP1138745A1 Organic electroluminescent element
10/04/2001EP1137649A2 Process for the preparation of pyrimidinone derivatives
10/04/2001EP1137644A1 Benzofuran derivatives, their preparation and use
10/04/2001EP1137640A1 Cyclic hydrazine derivatives as tnf-alpha inhibitors
10/04/2001EP1137638A2 Isoquinoline derivatives
10/04/2001EP1137413A2 Non-peptide antagonists of glp-1 receptor and methods of use
10/04/2001EP1087962A4 Preparation of heteroaryl compounds
10/04/2001EP0973395A4 Diaryl ethers and processes for their preparation and herbicidal and desiccant compositions containing them
10/04/2001EP0855999B1 1-(1,2-disubstituted piperidinyl)-4-substituted piperidine derivatives as tachykinin receptor antagonists
10/04/2001EP0821685B1 Indole-3-carbonyl and indole-3-sulfonyl derivatives as platelet activating factor antagonists
10/04/2001EP0815123B1 Beta-sheet mimetics and use thereof as protease inhibitors
10/04/2001EP0757673B1 Heterocyclylbenzonitriles
10/04/2001CA2404669A1 Condensed pyrazole derivatives, process for producing the same and use thereof
10/04/2001CA2404662A1 3-cyanoquinolines,3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
10/04/2001CA2404477A1 Tricyclic imidazopyridines
10/04/2001CA2404474A1 Prodrugs of imidazopyridine derivatives
10/04/2001CA2404466A1 Pyrano[2,3-c]imidazo[-1,2-a]pyridine derivatives for the treatment of gastrointestinal disorders
10/04/2001CA2404460A1 Alkylated imidazopyridine derivatives
10/04/2001CA2404455A1 Imidazopyridin-8-ones
10/03/2001CN1315951A FKBP inhibitors
10/03/2001CN1315830A Treatment of anxiety disorders
10/03/2001CN1072224C Condensed 'beta'-carbolines
10/02/2001US6297249 Integrin receptor antagonists
10/02/2001US6297248 1-aryl-1,8-naphthylidin-4-one derivative as type IV phosphodiesterase inhibitor
10/02/2001US6297234 Arylthiophene vasopressin agonists
10/02/2001US6297217 Boronic ester and acid compounds, synthesis and uses
10/02/2001CA2234567C Azaindole-ethylamine derivatives as nicotinic acetylcholine receptor binding agents
10/02/2001CA2037541C Azabicyclo and azacyclo oxime and amine cholinergic agents and methods of treatment
09/2001
09/27/2001WO2001070743A1 Non-amidine containing protease inhibitors
09/27/2001WO2001070742A1 4-hydroxy-1,8-naphthyridine-3-carboxamides as antiviral agents
09/27/2001WO2001070741A1 5-alkylpyrido[2,3-d]pyrimidines tyrosine kinase inhibitors
09/27/2001WO2001070740A1 Process for preparing crystalline form i of cabergoline
09/27/2001WO2001070731A1 Decahydro-isoquinolines
09/27/2001WO2001070728A1 2-[nitrogen-heterocyclic]pyrimidone derivatives
09/27/2001WO2001070675A2 Inhibitors of histone deacetylase
09/27/2001WO2001070337A1 Spiropiperidine derivatives as melanocortin receptor agonists
09/27/2001WO2001070269A1 Keratinocyte growth inhibitors and hydroxamic acid derivatives
09/27/2001WO2001070229A1 Thrombin inhibitors
09/27/2001WO2001060822A8 Amino acid derivatives and use thereof as nep, ace and ece inhibitors
09/27/2001WO2001019824A3 New active marine alkaloids
09/27/2001WO2001017972A3 Novel herbicides
09/27/2001WO2000061541A3 Pharmaceutical compounds
09/27/2001WO2000012047A3 Enhancement of return to independent living status with a growth hormone secretagogue
09/27/2001US20010025047 Nitrogen containing bicyclic heteroaromatic compound containing sulfonamide and hydroxyamide groups, useful in treatment of arthritis, tumor metastasis, tissue ulceration, abnormal wound healing, bone disease and HIV infections
09/27/2001US20010025043 New pharmaceutical active compounds
09/27/2001US20010025042 A fused nitrogen containing heterocyclic compound useful for treating psychiatric and neurological disorders, anxiety, post-traumatic stress, supranuclear palsy, feeding, immunological, cardiovascular and hypersensitivity disorders
09/27/2001US20010025039 Tricyclic aza-indolyl derivatives substituted with ethylamine group is useful for treating central nervous system disorder,cardiovascular disorder, gastrointestinal disorders, diabetes insipidus, and particularly useful for obesity
09/27/2001DE19960898A1 Preparation of a wide range of annelated pyrroles useful as photographic cyan dye couplers by reaction of heterocyclic carbonyl compounds with substituted phosphoric oxides or phosphonium salts in presence of a strong base
09/27/2001CA2404002A1 Inhibitors of histone deacetylase
09/27/2001CA2403631A1 Spiropiperidine derivatives as melanocortin receptor agonists
09/27/2001CA2403558A1 Thrombin inhibitors
09/27/2001CA2402836A1 Process for preparing crystalline form i of cabergoline
09/27/2001CA2402516A1 Non-amidine containing protease inhibitors
09/27/2001CA2401368A1 5-alkylpyrido[2,3-d]pyrimidines tyrosine kinase inhibitors
09/27/2001CA2399991A1 4-hydroxy-1,8-naphthyridine-3-carboxamides as antiviral agents
09/26/2001EP1136493A1 2-(Thienopyridinyl)pyrimidone, 2-(furopyridinyl)pyrimidone 2-(isoquinolinyl)pyrimidone, 2-(pyridoindolyl)pyrimidone and 2-(benzofuropyridinyl)pyrimidone derivatives
09/26/2001EP1136492A1 Sulfonamide compounds and uses thereof as medicines
09/26/2001EP1136483A1 2-[Piperazinyl]pyrimidone derivatives
09/26/2001EP1135389A1 1,4-diazabicyclo 3.2.2]nonane derivatives, their preparation and therapeutic application
09/26/2001EP0773943B1 Compounds useful as antiproliferative agents and garft inhibitors
09/26/2001CN1314912A Tartrate salt of a sabstituted dipentide as growth hormone secretagogue
09/26/2001CN1314345A Novel piperidine-4-sulfamide compound, its preparing method and medicinal composition containing them
09/25/2001US6294566 Imidazoline derivatives and uses thereof
09/25/2001US6294556 Arylglycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds
09/25/2001US6294547 Naphthyridine deratives or salts thereof
09/25/2001US6294532 Oxindolylquinazoline derivatives as angiogenesis inhibitors
09/25/2001US6294530 Heterocyclic compounds for nervous system disorders
09/25/2001US6294503 Herbicidal compositions containing heterocycles
09/20/2001WO2001068650A1 Perylene-derivative based crystallization modifiers
09/20/2001WO2001068649A1 Novel process for the preparation of a quinoline carboxylic acid derivative having a 7-(4-aminomethyl-3-oxime)pyrrolidine substituent
09/20/2001WO2001068648A1 Substituted beta-carbolines with ikb-kinase inhibiting activity
09/20/2001WO2001068608A1 -diketonato-metal complexes and process for the preparation thereof, photoelectric conversion devices and photoelectrochemical cells
09/20/2001WO2001068607A1 Amide compounds and use thereof
09/20/2001WO2001068097A1 Use of pyrido[3,2-e]-pyrazinones as inhibitors of phosphodiesterase 5 for treating erectile dysfunction
09/20/2001WO2001057038A9 Heterocyclic compounds and their use as parp inhibitors
09/20/2001WO2001027118A3 Bicyclic imidazo-5-yl-amine derivatives
09/20/2001WO2001027110A3 Bicyclic imidazo-3-yl-amine derivatives which are substituted on the sixth ring